Tumor agnostic efficacy of selpercatinib in patients with RET fusion+ solid tumors: A global, multicenter, registrational trial update (LIBRETTO-001).
暂无分享,去创建一个
A. Drilon | Y. Ohe | B. Konda | V. Subbiah | A. Spira | Hyunseok Kang | M. Takeda | S. Szymczak | K. Ohashi | J. Weiss | V. Soldatenkova | Jennifer Wright | Loretta Sullivan | Juergen Wolf | S. Khan